Jacaranda FM·3 min read·medium
Trials of two Ebola treatments to start in DRC next week: WHO
✦AI Summary
The World Health Organization is launching clinical trials for two new treatments to combat a rare Ebola outbreak in the Democratic Republic of Congo. The trials will test the efficacy of the monoclonal antibody MBP134 and the antiviral drug remdesivir.
Why it matters
Finding effective treatments for the rare Bundibugyo species of Ebola is critical to reducing mortality rates in an ongoing, deadly outbreak.
Updated June 25, 2026, 7:11 a.m. | By AFP
healthworld
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The report relies on official statements from the WHO and provides objective data regarding the outbreak and trial plans.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in